Abstract

Background: Age at symptom onset (ASO) is a prognostic factor that could affect the accrual of disability in multiple sclerosis (MS) patients. Some factors are known to influence the risk of multiple sclerosis (MS), but their influence on the ASO is less well-investigated.Objective: Examine the associations between known or emerging MS risk factors and ASO.Methods: This was a multicenter study, incident cases (n = 279) with first clinical diagnosis of demyelinating event aged 18–59 years recruited at four Australian centres (latitudes 27°-43°S), from 1 November 2003 to 31 December 2006. Environmental/behavioral variables and initial symptoms were recorded at baseline interview. Linear regression was used to assess the association between risk factors and ASO.Results: Five factors were significantly associated with ASO: a history of tobacco smoking was associated with 3.05-years later ASO (p = 0.002); a history of marijuana use was associated with 6.03-years earlier ASO (p < 0.001); progressive-onset cases had 5.61-years later ASO (p = 0.001); an initial presentation of bowel & bladder and cerebral dysfunctional were associated with 3.39 (p = 0.017) and 4.37-years (p = 0.006) later ASO, respectively. Other factors, including sex, offspring number, latitude of study site, history of infectious mononucleosis, HLA-DR15 & HLA-A2 genotype, 25(OH)D levels, and ultraviolet radiation exposure were not associated with ASO. Including all five significant variables into one model explained 12% of the total variance in ASO.Conclusion: We found a novel association between a history of tobacco smoking and later onset, whereas marijuana use was associated with earlier onset. Behavioral factors seem important drivers of MS onset timing although much of the variance remains unexplained.

Highlights

  • Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS), caused by a complex interplay between genetic and environmental factors [1]

  • In view of the conflicting evidence presented above, this paper examines the associations between risk factors for MS onset and at symptom onset (ASO) in a cohort recruited soon after the first clinical diagnosis of CNS demyelination (FCD)

  • All primary analyses were based on all patients with first demyelinating event (FDE) (n = 279), and sensitivity analyses including patients had converted to MS at 5year review (n = 217) or patients with FDE during recruitment period (n = 219) were presented in the last section of result

Read more

Summary

Introduction

Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS), caused by a complex interplay between genetic and environmental factors [1]. Our group recently demonstrated that these risk factors could explain 63.8% of the attributable risk [7], with 53.3% of that due to the environmental factors Other factors such as HLA-A2 genotype [8] (protective), offspring number [9] (protective), and marijuana use [5] (detrimental), have some evidence of involvement in MS risk. One study (n = 816) found that cases with HLA-DR15 risk genotype had roughly 2.5-years earlier onset [15], but a later metaanalysis (n = 2,201) showed no association [16]. Age at symptom onset (ASO) is a prognostic factor that could affect the accrual of disability in multiple sclerosis (MS) patients. Some factors are known to influence the risk of multiple sclerosis (MS), but their influence on the ASO is less well-investigated

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call